Optimi Health is trading at $4.95 (8.3% up) in pre-market sessions, continuing to gain traction following its recent uplisting to the Nasdaq Capital Market and a successful oversubscribed $15 million financing round.
- The stock has remained volatile since its listing, with current price action driven by sustained investor interest in newly listed psychedelic and health-related names.
- There have been no fresh company-specific announcements today, suggesting the move is a continuation of the momentum from its recent transition to the Nasdaq.